• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Enabling Statisticians to Lead through Innovation and Excellence

    Enabling Statisticians to Lead through Innovation and Excellence

Search The Effective Statistician

  • Winning with Words and Graphs: The Effective Statistician presentation and data visualization masterclass
  • How to be an effective statistician
  • Start here!
  • Podcast
    • PSI Careers
  • Free resources on visualization
    • Recording available: Flatten the curve – learnings from COVID-19 visualizations to better explore and communicate your data
  • Free resources on influencing
    • The Effective Statistician Leadership Program
    • Recording available: It’s not enough to be right!
  • Join The Effective Statistician LinkedIn group
  • Quick tips to be more effective
  • Legal disclosure – about us
    • Datenschutzerklärung – sorry, still in German…
You are here: Home / Knowledge / What is the best career option for me?

What is the best career option for me?

By Alexander on 2019-03-26 0

What is the best career option for me?
  • share 
  • tweet  
  • share  
  • share 
  • save  

Interview with Oliver Schoenborn-Kellenberger

Do you want to change your job?
Are you just looking for you first job?
Do you consider to work for your own company or as a free-lancer?

Then this episode will help you!

Oliver has accrued lots of experience working in different set ups over his career and thus is able to tell about the different strengths and limitations of the set-ups.

Furthermore, Benjamin and myself bring in the perspective of CRO and pharma statisticians and supervisors.

In this episode, we cover:

  • Why starting at a CRO might or might not be the right thing for you?
  • How does working for a large pharma organisation look like.
  • How is it different to work for a CRO compared to a large pharma company?
  • What are the development options at a large pharma organisation?
  • How it’s like to work in a biotech company – especially compared to large pharma.
  • If starting your own company or working as a free-lancer offers benefits for you.
  • What is the most important career advice in terms of choosing the right company from Oliver.

About Oliver Schönborn-Kellenberger

Oliver Schönborn-Kellenberger received his MSc in Mathematics at Georg August University in Göttingen.

In 2004 he started as statistician at a CRO [PRA] before joining Novartis Pharma AG in 2006. In 2008, he moved to Novartis Oncology where he took over responsibility for a large compound in early development. He pursued an opportunity at Imclone International in 2012.

Oliver Schönborn-Kellenberger has specific expertise in management of transition activities (Proof of Concept/Phase II to Phase III).

During his career, he was involved in various fully Bayesian single agent and combination escalation trials as well as in Bayesian Phase II trials. His project experience includes Hsp90, pan-RAF, Notch inhibitors and bispecific antibody and amongst others, he worked in indications such as NSCLC, gastric tumors and hodgkin lymphoma.

Never miss an episode of The Effective Statistician

Join hundreds of your peers and subscribe to get our latest updates by email!

Get the shownotes of our podcast episodes plus tips and tricks to increase your impact at work to boost your career!

Success! Now check your email to confirm your subscription.

There was an error submitting your subscription. Please try again.

We won't send you spam. Unsubscribe at any time. Powered by ConvertKit
  • share 
  • tweet  
  • share  
  • share 
  • save  

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Join the PSI newsletter here!

Categories

  • Excellence
  • Innovation
  • Knowledge
  • Leadership
  • PSI Calc Podcast

Recent Posts

  • Extrapolation to paedriatics
  • How to integrate external data into your clinical studies: from theory to application
  • A preview into the PSI conference
  • Patient-reported outcomes and the FDA Patient-Focused Drug Development Guidance
  • Apps on prescription paid by the government

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018

The podcast is run in association with PSI

Copyright © 2022 · Smart Passive Income Pro on Genesis Framework · WordPress · Log in